Targeting Crohn's disease

Affiliations

Comment

Stephen B Hanauer. Lancet. 2017.

. 2017 Dec 23;390(10114):2742-2744.

doi: 10.1016/S0140-6736(17)32754-X. Epub 2017 Oct 31.

¹ Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: shanauer@northwestern.edu.

No abstract available

Comment on

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Colombel JF, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T, Danalioglu A, Novacek G, Armuzzi A, Hébuterne X, Travis S, Danese S, Reinisch W, Sandborn WJ, Rutgeerts P, Hommes D, Schreiber S, Neimark E, Huang B, Zhou Q, Mendez P, Petersson J, Wallace K, Robinson AM, Thakkar RB, D'Haens G. Colombel JF, et al. Lancet. 2017 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31. Lancet. 2017. PMID: 29096949 Clinical Trial.